Loading...
•
Sep 30, 2024
PetMed Express Q2 2025 Earnings Report
PetMed Express's profitability improved and key initiatives advanced.
Key Takeaways
PetMed Express reported net sales of $59.6 million and a net income of $2.3 million, or $0.11 per diluted share, for the second quarter of fiscal year 2025. The company saw a gross margin of 29.1%, an increase of 0.8% compared to the prior year period. Adjusted EBITDA improved sequentially to $2.1 million.
Net sales reached $59.6 million.
Gross margin increased to 29.1%, up 0.8% year-over-year.
Net income was $2.3 million, or $0.11 per diluted share.
Adjusted EBITDA improved sequentially to $2.1 million.
PetMed Express
PetMed Express
Forward Guidance
The company is focusing on differentiating product assortments, brand awareness campaigns, and core marketing initiatives to drive growth and create a compelling value proposition for stakeholders.